Format

Send to

Choose Destination
Am J Kidney Dis. 2014 Aug;64(2):278-89. doi: 10.1053/j.ajkd.2014.02.025. Epub 2014 Apr 18.

Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes.

Author information

1
Centre for Kidney Disease Research, Translational Research Institute at University of Queensland, Brisbane, Australia; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
2
Centre for Kidney Disease Research, Translational Research Institute at University of Queensland, Brisbane, Australia; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia. Electronic address: david.johnson2@health.qld.gov.au.

Abstract

Peritonitis is a common serious complication of peritoneal dialysis that results in considerable morbidity, mortality, and health care costs. It also significantly limits the use of this important dialysis modality. Despite its importance as a patient safety issue, peritonitis practices and outcomes vary markedly and unacceptably among different centers, regions, and countries. This article reviews peritonitis risk factors, diagnosis, treatment, and prevention, particularly focusing on potential drivers of variable practices and outcomes, controversial or unresolved areas, and promising avenues warranting further research. Potential strategies for augmenting the existing limited evidence base and reducing the gap between evidence-based best practice and actual practice also are discussed.

KEYWORDS:

Antibiotics; bacteria; fungi; microbiology; outcomes; peritoneal dialysis; peritonitis; practice variation; prevention; quality improvement; risk factors

PMID:
24751170
DOI:
10.1053/j.ajkd.2014.02.025
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center